Postmarketing surveillance of elobixibat for patients with chronic constipation and concomitant schizophrenia or depression in Japan - Top-Institutions - MDSpire

Postmarketing surveillance of elobixibat for patients with chronic constipation and concomitant schizophrenia or depression in Japan

  • By

  • Yoshiteru Takekita

  • Minami Umeyama

  • Mie Iwaida

  • Masaaki Higashikawa

  • Yusuke Shimada

  • Atsushi Nakajima

  • April 20, 2026

  • 0 min

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    The University of Tokyo Hospital
    The University of Tokyo Hospital

    Tokyo, Tokyo

    Key Differentiators

    • Gastroenterology
    • Psychiatry
    • Clinical Pharmacology

  • #2

    Kyoto University Hospital
    Kyoto University Hospital

    Kyoto, Kyoto

    Key Differentiators

    • Gastroenterology
    • Psychiatry

  • #3

    Osaka University Hospital
    Osaka University Hospital

    Osaka, Osaka

    Key Differentiators

    • Gastroenterology
    • Psychiatry

  • #4

    National Center of Neurology and Psychiatry (NCNP)
    National Center of Neurology and Psychiatry (NCNP)

    Kodaira, Tokyo

    Key Differentiators

    • Psychiatry
    • Neurogastroenterology

  • #5

    Tohoku University Hospital
    Tohoku University Hospital

    Sendai, Miyagi

    Key Differentiators

    • Gastroenterology
    • Psychiatry

Original Source(s)

Postmarketing surveillance of elobixibat for patients with chronic constipation and concomitant schizophrenia or depression in Japan

  • by Yoshiteru Takekita, Minami Umeyama, Mie Iwaida, Masaaki Higashikawa, Yusuke Shimada, Atsushi Nakajima

  • April 20, 2026

Related Content

Mind Matters: Mental Health and Diabetes Management

From Weight Bias Internalization to Health-Related Quality of Life: Self-esteem and Psychopathology in Pre-bariatric Surgery Patients

Health-related Quality of Life, Social, and Psychological Well-Being of 109 Adult Patients With Genetic Lipodystrophy